Pancreatic Cancer Research

ResearcherUtrecht UniversityActive in the last 2 years

Lilly J. H. Brada

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0985-0725; OpenAlex author ID A5016427359. Sources: OpenAlex.

Their work

Papers
12 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
50
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 5 papers · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper

Papers 12

  1. Radiofrequency Ablation and Chemotherapy vs Chemotherapy Only in Locally Advanced Pancreatic Cancer: The PELICAN Randomized Clinical Trial. First author DOI 10.1001/jamanetworkopen.2026.3861↗
  2. Evaluation of Short and Long-term Outcomes After Resection in Patients With Locally Advanced Versus (Borderline) Resectable Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000006289↗
  3. Nationwide implementation of the international multidisciplinary best-practice for locally advanced pancreatic cancer (PREOPANC-4): study protocol. Co-author DOI 10.1186/s12885-025-13554-w↗
  4. Minimum and Optimal CA19-9 Response After Two Months Induction Chemotherapy in Patients With Locally Advanced Pancreatic Cancer: A Nationwide Multicenter Study. Co-author DOI 10.1097/sla.0000000000006021↗
  5. Early Recurrence After Resection of Locally Advanced Pancreatic Cancer Following Induction Therapy: An International Multicenter Study. Co-author DOI 10.1097/sla.0000000000005666↗
  6. Preoperative predictors for early and very early disease recurrence in patients undergoing resection of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.hpb.2021.09.004↗
  7. Predicting overall survival and resection in patients with locally advanced pancreatic cancer treated with FOLFIRINOX: Development and internal validation of t… Co-author DOI 10.1002/jso.26567↗
  8. Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicenter prospective cohort. First author DOI 10.1016/j.ejso.2020.11.137↗
  9. The treatment and survival of elderly patients with locally advanced pancreatic cancer: A post-hoc analysis of a multicenter registry. Co-author DOI 10.1016/j.pan.2020.11.012↗
  10. Survival Benefit Associated With Resection of Locally Advanced Pancreatic Cancer After Upfront FOLFIRINOX Versus FOLFIRINOX Only: Multicenter Propensity Score-… Co-author DOI 10.1097/sla.0000000000005120↗
  11. Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled… Co-author DOI 10.1186/s13063-021-05248-y↗
  12. Locally Advanced Pancreatic Cancer: Work-Up, Staging, and Local Intervention Strategies. Co-author DOI 10.3390/cancers11070976↗

Closest collaborators

The 25 strongest of 50 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Izaak Quintus Molenaar · 10 shared papers, 2019–2025 · strength 1.12
  2. Hjalmar C. van Santvoort · 10 shared papers, 2019–2025 · strength 1.12
  3. Marc G. Besselink · 10 shared papers, 2019–2025 · strength 1.12
  4. Ignace H. J. T. de Hingh · 9 shared papers, 2021–2025 · strength 1.04
  5. Martijn W.J. Stommel · 9 shared papers, 2021–2025 · strength 1.04
  6. Marieke S. Walma · 9 shared papers, 2019–2025 · strength 1.01
  7. Gijs A. Patijn · 8 shared papers, 2021–2025 · strength 0.93
  8. Vincent Erwin de Meijer · 8 shared papers, 2021–2025 · strength 0.91
  9. Sebastiaan Festen · 8 shared papers, 2021–2025 · strength 0.91
  10. Lois A. Daamen · 5 shared papers, 2021–2025 · strength 0.64
  11. Nadia Haj Mohammad · 6 shared papers, 2021–2024 · strength 0.60
  12. Bas Groot Koerkamp · 5 shared papers, 2019–2024 · strength 0.56
  13. Leonard W. F. Seelen · 3 shared papers, 2023–2025 · strength 0.49
  14. Johanna W. Wilmink · 5 shared papers, 2019–2024 · strength 0.48
  15. Casper H.J. van Eijck · 4 shared papers, 2019–2024 · strength 0.45
  16. Krijn P. van Lienden · 5 shared papers, 2019–2021 · strength 0.42
  17. Martijn Ruben Meijerink · 4 shared papers, 2019–2021 · strength 0.33
  18. Freek D. Daams · 3 shared papers, 2021–2024 · strength 0.31
  19. Thijs J. Schouten · 2 shared papers, 2021–2025 · strength 0.29
  20. Judith de Vos‐Geelen · 3 shared papers, 2021 · strength 0.25
  21. A. Floortje van Oosten · 2 shared papers, 2022–2023 · strength 0.24
  22. Vincent P. Groot · 2 shared papers, 2022–2023 · strength 0.24
  23. Christopher Lee Wolfgang · 2 shared papers, 2019–2023 · strength 0.21
  24. Hanneke W. Wilmink · 2 shared papers, 2021 · strength 0.19
  25. Steffi J. E. Rombouts · 2 shared papers, 2021 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.